Platform
Features
0 followers
reMYND drives the development of disease-modifying treatments against protein misfolding disorders.
Industries
Headquarters
Employees
Links
Gerard Griffioen
3 members
1 members
Kura Oncology
19 followers
argenx
15 followers
Evaxion Biotech
6 followers
REVOLUTION Medicines
5 followers
DBV Technologies
Halozyme Therapeutics
4 followers
C4 Therapeutics
Stemline Therapeutics
3 followers
CytomX
Loam Bio
Vow
Explore companies